Shin Maeda Selected Research

Radiotherapy

3/2021	Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma.
1/2019	Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.
6/2013	Postpyloric decompression tube placement through a gastrostomy for malignant bowel obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shin Maeda Research Topics

Disease

61	Neoplasms (Cancer) 11/2022 - 09/2004
57	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 03/2009
28	Inflammation (Inflammations) 04/2021 - 09/2004
28	Carcinogenesis 01/2021 - 12/2003
13	Stomach Neoplasms (Stomach Cancer) 10/2015 - 03/2002
12	Infections 01/2022 - 02/2002
9	Hemorrhage 04/2022 - 01/2008
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2011
7	Liver Neoplasms (Liver Cancer) 10/2021 - 07/2007
7	Fibrosis (Cirrhosis) 04/2021 - 01/2012
7	Neoplasm Metastasis (Metastasis) 06/2020 - 09/2004
6	Adenocarcinoma 11/2022 - 01/2011
6	Liver Diseases (Liver Disease) 01/2021 - 01/2011
6	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 04/2009
5	Necrosis 01/2022 - 08/2008
5	Chronic Hepatitis C 03/2021 - 11/2009
5	Colitis 05/2015 - 08/2007
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2017 - 09/2007
4	Aberrant Crypt Foci 09/2014 - 01/2010
4	Non-alcoholic Fatty Liver Disease 11/2013 - 11/2011
4	Colitis-Associated Neoplasms 06/2010 - 08/2007
3	Neutropenia 01/2022 - 01/2018
3	Ulcerative Colitis 04/2021 - 04/2011
3	Diarrhea 02/2021 - 01/2020
3	Hypersensitivity (Allergy) 02/2021 - 01/2011
3	Thrombosis (Thrombus) 02/2021 - 01/2017
3	Peptic Ulcer (Peptic Ulcers) 01/2018 - 07/2011
3	Colonic Neoplasms (Colon Cancer) 10/2015 - 09/2004
3	Gastritis 01/2013 - 02/2008
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 05/2020
2	Febrile Neutropenia 01/2022 - 01/2018
2	Anorexia 01/2022 - 01/2018
2	Polyps 04/2021 - 09/2012
2	Sclerosing Cholangitis 04/2021 - 01/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2021 - 01/2021
2	Pathologic Constriction (Stenosis) 02/2021 - 03/2011
2	Thrombocytopenia (Thrombopenia) 01/2021 - 06/2020
2	Gastric Outlet Obstruction 08/2020 - 01/2015
2	Pancreatitis 01/2020 - 03/2011
2	Vomiting 01/2020 - 03/2011

Drug/Important Bio-Agent (IBA)

19	NF-kappa B (NF-kB)IBA 07/2010 - 09/2004
10	lenvatinibIBA 01/2022 - 01/2020
10	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 02/2012
10	Pharmaceutical PreparationsIBA 06/2020 - 10/2008
10	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2010
8	Contrast MediaIBA 01/2022 - 10/2012
8	Mitogen-Activated Protein KinasesIBA 02/2014 - 03/2002
8	I-kappa B KinaseIBA 04/2009 - 02/2005
7	GadoliniumIBA 06/2021 - 01/2012
7	Phosphotransferases (Kinase)IBA 04/2012 - 07/2008
6	Pentetic Acid (DTPA)FDA LinkGeneric 06/2021 - 01/2012
6	perfluorobutane (AI 700)IBA 01/2020 - 10/2012
6	CarcinogensIBA 12/2017 - 12/2003
6	Interleukin-6 (Interleukin 6)IBA 01/2013 - 07/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 09/2004
5	Insulin (Novolin)FDA Link 08/2021 - 02/2005
5	Therapeutic UsesIBA 07/2020 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2006
4	SonazoidIBA 06/2021 - 05/2017
4	Cadherins (E-Cadherin)IBA 04/2021 - 01/2014
4	Dextran SulfateIBA 05/2015 - 08/2007
4	Virulence Factors (Pathogenicity Factors)IBA 11/2012 - 02/2002
3	EnzymesIBA 01/2022 - 02/2005
3	BilirubinIBA 02/2021 - 01/2020
3	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 02/2021 - 01/2017
3	SteroidsIBA 10/2018 - 04/2011
3	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2013 - 07/2008
3	CytokinesIBA 01/2013 - 01/2010
3	LigandsIBA 11/2011 - 08/2009
3	MAP Kinase Kinase Kinase 5IBA 07/2011 - 03/2010
3	AzoxymethaneIBA 03/2010 - 01/2009
3	SaltsIBA 10/2007 - 08/2007
2	Bevacizumab (Avastin)FDA Link 03/2022 - 08/2021
2	atezolizumabIBA 03/2022 - 08/2021
2	Gemcitabine FDA Link 01/2022 - 10/2019
2	folfirinoxIBA 01/2022 - 01/2018
2	130-nm albumin-bound paclitaxelIBA 01/2022 - 10/2019
2	Epirubicin (Ellence)FDA LinkGeneric 06/2021 - 12/2017
2	Capsules (Microcapsules)IBA 04/2021 - 01/2013
2	SofosbuvirIBA 03/2021 - 12/2020
2	Antiviral Agents (Antivirals)IBA 03/2021 - 12/2020
2	Penicillins (Penicillin)FDA Link 02/2021 - 01/2017
2	PlasticsIBA 02/2021 - 02/2015
2	Metronidazole (Metric)FDA LinkGeneric 02/2021 - 01/2017
2	AlbuminsIBA 02/2021 - 06/2020
2	acarboxyprothrombin (PIVKA)IBA 11/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 10/2018

Therapy/Procedure

28	Therapeutics 08/2022 - 01/2011
15	Radiofrequency Ablation 01/2022 - 03/2012
13	Drug Therapy (Chemotherapy) 01/2022 - 11/2011
6	Stents 07/2021 - 01/2011
3	Ligation 01/2022 - 07/2002
3	Gastrostomy 07/2021 - 06/2013
3	Radiotherapy 03/2021 - 06/2013
2	Surgical Instruments (Clip) 04/2022 - 02/2021
2	Liver Transplantation 10/2021 - 03/2011
2	Microspheres (Microsphere) 06/2021 - 08/2015
2	Hepatectomy 02/2021 - 08/2011
2	Self Expandable Metallic Stents 02/2021 - 01/2015